Larimar Therapeutics, Inc. (LRMR)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
16-Feb-24 2:37 PM
View: 
Flynn James E
Director
10% Owner
Larimar Therapeutics, Inc. (LRMR) 16-Feb-24Market Purchase 4,290,620$8.74$37,500,000.0025%
16.94M to 21.23M
5%
15-Feb-24 4:21 PM
View: 
Thomas Frank E
Director
Larimar Therapeutics, Inc. (LRMR) 14-Feb-24Purchase 2,000$11.00$22,000.00100%
0 to 2.0K
19-Jan-24 4:32 PM
View: 
Celano Michael
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 17-Jan-24Grant 31,250----28%
112.75K to 144.0K
19-Jan-24 4:31 PM
View: 
Ben-Maimon Carole
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 17-Jan-24Grant 66,125----25%
266.83K to 332.95K
19-Jan-24 4:33 PM
View: 
Shankar Gopi
Chief Development Officer
Larimar Therapeutics, Inc. (LRMR) 17-Jan-24Grant 22,500----450%
5.0K to 27.5K
19-Jan-24 4:31 PM
View: 
Clayton Russell
Chief Medical Officer
Larimar Therapeutics, Inc. (LRMR) 17-Jan-24Grant 22,500----100%
0 to 22.5K
08-Dec-23 4:08 PM
View: 
Shankar Gopi
Chief Development Officer
Larimar Therapeutics, Inc. (LRMR) 07-Dec-23Private Purchase 5,000$3.73$18,661.50100%
0 to 5.0K
18-May-23 2:12 PM
View: 
Truitt Joseph
Director
Larimar Therapeutics, Inc. (LRMR) 17-May-23Private Purchase 2,750$3.73$10,257.50100%
0 to 2.75K
18-May-23 2:13 PM
View: 
Celano Michael
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 17-May-23Private Purchase 5,000$3.73$18,631.505%
107.75K to 112.75K
18-May-23 2:13 PM
View: 
Ben-Maimon Carole
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 17-May-23Private Purchase 5,000$3.70$18,525.002%
261.83K to 266.83K
02-Feb-23 8:16 PM
View: 
Celano Michael
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 31-Jan-23Grant 76,000----239%
31.75K to 107.75K
02-Feb-23 8:15 PM
View: 
Ben-Maimon Carole
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 31-Jan-23Grant 205,000----361%
56.83K to 261.83K
20-Sep-22 6:54 AM
View: 
Hamilton Thomas Edward
Director
Larimar Therapeutics, Inc. (LRMR) 16-Sep-22Private Purchase 317,460$3.15$999,999.0091%
349.56K to 667.02K
20-Sep-22 8:31 PM
View: 
Flynn James E
Director
10% Owner
Larimar Therapeutics, Inc. (LRMR) 16-Sep-22Private Purchase 11,111,100$3.15$35,000,000.00191%
5.83M to 16.94M
19-Sep-22 7:00 AM
View: 
Celano Michael
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 16-Sep-22Private Purchase 31,746$3.15$99,999.90100%
0 to 31.75K
19-Sep-22 7:00 AM
View: 
Ben-Maimon Carole
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 16-Sep-22Private Purchase 31,746$3.15$99,999.90127%
25.08K to 56.83K
02-Jul-21 10:00 PM
View: 
Flynn James E
Director
10% Owner
Larimar Therapeutics, Inc. (LRMR) 30-Jun-21Market Purchase 685,710$8.75$5,999,960.0013%
5.14M to 5.83M
11%
30-Jun-20 5:02 PM
View: 
Hamilton Thomas Edward
Director
Larimar Therapeutics, Inc. (LRMR) 26-Jun-20Acquisition (other) 133,420----100%
133.42K to 266.84K
30-Jun-20 5:01 PM
View: 
Chondrial Therapeutics Hold...
10% Owner
Larimar Therapeutics, Inc. (LRMR) 26-Jun-20Disposition (other) 6,091,240----(100%)
6.09M to 8
30-Jun-20 5:02 PM
View: 
Hamilton Thomas Edward
Director
Larimar Therapeutics, Inc. (LRMR) 26-Jun-20Acquisition (other) 159,433----60%
266.84K to 426.27K
30-Jun-20 5:00 PM
View: 
Ben-Maimon Carole
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 26-Jun-20Acquisition (other) 25,083----100%
0 to 25.08K
28-Jan-19 7:01 PM
View: 
Lamattina John L
Director
Larimar Therapeutics, Inc. (LRMR) 24-Jan-19Grant 10,844$4.38$47,496.7053%
20.53K to 31.38K
195%
28-Jan-19 7:01 PM
View: 
Perez Robert J
Director
Larimar Therapeutics, Inc. (LRMR) 24-Jan-19Grant 4,423$4.38$19,372.7068%
6.46K to 10.89K
195%
02-Jul-18 4:01 PM
View: 
Atlas Venture Fund Vii L P
10% Owner
Larimar Therapeutics, Inc. (LRMR) 29-Jun-18Disposition (other) 1,360,870----(28%)
4.87M to 3.51M
29-Jun-18 7:01 PM
View: 
Hughes Thomas E.
See Remarks
Director
Larimar Therapeutics, Inc. (LRMR) 28-Jun-18Market Sale (Planned) 32,000$10.00$320,000.00(20%)
157.25K to 125.25K
(29%)
09-Mar-18 6:00 PM
View: 
Hughes Thomas E.
See Remarks
Director
Larimar Therapeutics, Inc. (LRMR) 07-Mar-18Market Sale (Planned) 5,000$10.00$50,000.00(3%)
162.25K to 157.25K
(29%)
05-Jan-18 5:01 PM
View: 
Lamattina John L
Director
Larimar Therapeutics, Inc. (LRMR) 03-Jan-18Grant 9,169$5.18$47,495.4081%
11.36K to 20.53K
150%
05-Jan-18 5:02 PM
View: 
Daniel Thomas O
Director
Larimar Therapeutics, Inc. (LRMR) 03-Jan-18Grant 8,687$5.18$44,998.7081%
10.77K to 19.45K
150%
17-Oct-17 5:11 PM
View: 
Heller Frances K
Director
Larimar Therapeutics, Inc. (LRMR) 13-Oct-17Market Purchase 10,000$3.90$38,988.0026%
37.96K to 47.96K
231%
12-Jul-17 4:05 PM
View: 
Kim Dennis D
Chief Medical Officer
Larimar Therapeutics, Inc. (LRMR) 11-Jul-17Market Purchase 10,000$3.39$33,900.0087%
11.44K to 21.44K
281%
15-May-17 8:22 PM
View: 
Hughes Thomas E.
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 11-May-17Option Exercise 93,211$0.80$74,673.40145%
64.16K to 157.37K
11-May-17 6:59 PM
View: 
Kim Dennis D
Chief Medical Officer
Larimar Therapeutics, Inc. (LRMR) 11-May-17Market Purchase 9,800$4.40$43,120.00596%
1.64K to 11.44K
193%
11-May-17 6:59 PM
View: 
Kim Dennis D
Chief Medical Officer
Larimar Therapeutics, Inc. (LRMR) 10-May-17Market Purchase 200$4.40$880.0014%
1.44K to 1.64K
193%
14-Feb-17 8:14 PM
View: 
Daniel Thomas O
Director
Larimar Therapeutics, Inc. (LRMR) 13-Feb-17Grant 10,765$4.18$44,997.70100%
0 to 10.77K
209%
14-Feb-17 8:07 PM
View: 
Lamattina John L
Director
Larimar Therapeutics, Inc. (LRMR) 13-Feb-17Grant 11,363$4.18$47,497.30100%
0 to 11.36K
209%
20-Dec-16 5:02 PM
View: 
Heller Frances K
Director
Larimar Therapeutics, Inc. (LRMR) 19-Dec-16Market Purchase 10,000$3.23$32,290.0050%
20.0K to 30.0K
289%
17-Nov-16 5:00 PM
View: 
Heller Frances K
Director
Larimar Therapeutics, Inc. (LRMR) 15-Nov-16Market Purchase 10,000$3.54$35,434.00100%
10.0K to 20.0K
246%
31-Aug-16 4:15 PM
View: 
Hughes Thomas E.
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 29-Aug-16Market Purchase 10,000$3.00$29,987.0019%
53.94K to 63.94K
309%
26-Jul-16 5:10 PM
View: 
Allen Patricia L
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 26-Jul-16Market Purchase 8,200$3.15$25,830.0071%
11.59K to 19.79K
290%
26-Jul-16 5:10 PM
View: 
Allen Patricia L
Chief Financial Officer
Larimar Therapeutics, Inc. (LRMR) 25-Jul-16Market Purchase 7,800$3.08$24,031.80206%
3.79K to 11.59K
299%
26-Jul-16 5:14 PM
View: 
Hughes Thomas E.
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 22-Jul-16Option Exercise 25,000$0.75$18,750.00104%
23.94K to 48.94K
26-Jul-16 5:09 PM
View: 
Heller Frances K
Director
Larimar Therapeutics, Inc. (LRMR) 22-Jul-16Market Purchase 10,000$2.99$29,900.00100%
0 to 10.0K
311%
26-Jul-16 5:14 PM
View: 
Hughes Thomas E.
President and CEO
Director
Larimar Therapeutics, Inc. (LRMR) 22-Jul-16Market Purchase 5,000$3.02$15,104.0010%
48.94K to 53.94K
306%
01-Aug-16 7:14 PM
View: 
Flynn James E
10% Owner
Larimar Therapeutics, Inc. (LRMR) 20-Jul-16Market Sale 1,341,500$3.31$4,442,780.00(44%)
3.06M to 1.71M
(271%)
04-Apr-16 9:00 PM
View: 
McDonough Cameron Geoffrey
Director
Larimar Therapeutics, Inc. (LRMR) 01-Apr-16Disposition 4,424$7.91$34,993.80(100%)
4.42K to 0
17-Feb-16 2:02 PM
View: 
Flynn James E
10% Owner
Larimar Therapeutics, Inc. (LRMR) 12-Feb-16Market Purchase 64,545$6.25$403,187.002%
2.99M to 3.06M
97%
11-Feb-16 8:21 PM
View: 
Flynn James E
10% Owner
Larimar Therapeutics, Inc. (LRMR) 11-Feb-16Market Purchase 2,344$6.19$14,505.60< 1%
2.99M to 2.99M
98%
11-Feb-16 8:21 PM
View: 
Flynn James E
10% Owner
Larimar Therapeutics, Inc. (LRMR) 10-Feb-16Market Purchase 151,226$6.23$942,486.005%
2.84M to 2.99M
97%
11-Feb-16 8:21 PM
View: 
Flynn James E
10% Owner
Larimar Therapeutics, Inc. (LRMR) 09-Feb-16Market Purchase 113,923$5.73$652,676.004%
2.72M to 2.84M
114%
27-Jan-16 9:18 PM
View: 
Booth Bruce
Director
10% Owner
Larimar Therapeutics, Inc. (LRMR) 25-Jan-16Grant 4,424$7.91$34,993.80< 1%
4.63M to 4.64M
55%